Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(4.44)
# 301
Out of 5,129 analysts
22
Total ratings
62.5%
Success rate
31.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Upgrades: Overweight | $6 → $13 | $8.56 | +51.87% | 2 | Dec 12, 2025 | |
| ZYME Zymeworks | Upgrades: Overweight | $25 → $33 | $22.39 | +47.39% | 4 | Dec 12, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Equal-Weight | $8 → $11 | $14.54 | -24.35% | 3 | Nov 11, 2025 | |
| IMCR Immunocore Holdings | Initiates: Overweight | $60 | $32.61 | +83.99% | 1 | Oct 31, 2025 | |
| RCUS Arcus Biosciences | Maintains: Overweight | $25 → $29 | $20.27 | +43.07% | 4 | Oct 20, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Overweight | $42 → $45 | $43.37 | +3.76% | 3 | Sep 25, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $67 → $70 | $94.60 | -26.00% | 1 | Sep 11, 2025 | |
| XNCR Xencor | Maintains: Overweight | $33 → $27 | $11.80 | +128.81% | 3 | Aug 7, 2025 | |
| IDYA IDEAYA Biosciences | Initiates: Overweight | $44 | $32.29 | +36.27% | 1 | Jun 26, 2025 |
Relay Therapeutics
Dec 12, 2025
Upgrades: Overweight
Price Target: $6 → $13
Current: $8.56
Upside: +51.87%
Zymeworks
Dec 12, 2025
Upgrades: Overweight
Price Target: $25 → $33
Current: $22.39
Upside: +47.39%
Bicara Therapeutics
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $14.54
Upside: -24.35%
Immunocore Holdings
Oct 31, 2025
Initiates: Overweight
Price Target: $60
Current: $32.61
Upside: +83.99%
Arcus Biosciences
Oct 20, 2025
Maintains: Overweight
Price Target: $25 → $29
Current: $20.27
Upside: +43.07%
Kiniksa Pharmaceuticals International,
Sep 25, 2025
Maintains: Overweight
Price Target: $42 → $45
Current: $43.37
Upside: +3.76%
Revolution Medicines
Sep 11, 2025
Maintains: Overweight
Price Target: $67 → $70
Current: $94.60
Upside: -26.00%
Xencor
Aug 7, 2025
Maintains: Overweight
Price Target: $33 → $27
Current: $11.80
Upside: +128.81%
IDEAYA Biosciences
Jun 26, 2025
Initiates: Overweight
Price Target: $44
Current: $32.29
Upside: +36.27%